Devopharma ApS is a Danish APS based in Charlottenlund, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2017, the company reported revenue of -3,1 t kr. in its latest annual filing.
Solidity ratio Equity ÷ Total assets × 100 2021 2025
Liquidity ratio Current assets ÷ Short-term debt 2021 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 2021 2025
EBITDA — year on year DKK millions 0M 0M 0M -1M -1M 2021: 0M 0M 2021 2022: 0M 0M 2022 2023: 0M 0M 2023 2024: 0M 0M 2024 2025: 0M 0M 2025
Key figures Annual report 2025 Revenue -3,1 t. kr. 0% EBITDA -3,1 t. kr. 0% Net profit -3,1 t. kr. 0% Total assets 100 t. kr. 0% Equity 25 t. kr. -11% Employees — —
Founded
25 September 2017 · 8 years
Financial year
January – December
Signatory rights
Selskabet tegnes af selskabets direktion
Company purpose
Selskabets formål er at udøve virksomhed med forskning og eksperimentel udvikling indenfor bioteknologi
(no translation available)
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development In its most recent annual report (2025), Devopharma ApS reported a gross profit of -3,1 t kr.. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 3,1 t kr..
At the end of 2025, equity financed 25% of the balance sheet, and current assets covered short-term debt 0.7 times. Devopharma ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of Devopharma ApS? Devopharma ApS is registered with CVR / Virk under CVR 38968254.
What is the revenue of Devopharma ApS? Devopharma ApS reported revenue of -3,1 t kr. in 2025.
Where is Devopharma ApS headquartered? Devopharma ApS's registered address is Strandvejen 301, 2..
